Oncolix owns 2/3s of the OS... if they RS they would be splitting their own 60M shares too... why on earth would they?!If anyone can answer that with any reasonable answer then I'll consider an RS. They don't need to RS to uplist either, all it will take to trade in dollars with this share structure is an announcement of merger final and good results on clinical trials.
On April 6, 2017, Interim Management completed the sale 61,465,130 shares of common stock (including the 1,465,130 shares previously owned and the 60,000,000 shares received to implement the debt extinguishment plan) to Oncolix. Interim Management resigned all positions with the Company, and two officers of Oncolix were appointed as the sole Directors of AEPP, resulting in a change in control of AEPP.
News 
Market Data 
Discover 
AI
